James Lind Initiative Database of Uncertainties about the Effects of Treatments (DUETs) what gaps in the evidence matter to patients and doctors? Iain.

Slides:

Advertisements

Similar presentations

The CASA Project IACFS/ME September 23, CASA ME/CFS Patient Data Need a Home! C ollection A ggregation S torage A nalysis.

Advertisements

Case studies: Identifying the treatment uncertainties of people with asthma & their clinicians Colin Gelder Asthma Editor DUETs.

February 2008 Providing evidence based resources.

Department of Medicines Policy and Standards The WHO Model List of Essential Medicines – Palliative Care update Suzanne Hill World Health Organisation.

UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.

A New Vision for Chronic Osteoarthritis Management A Call to Action from the Chronic Osteoarthritis Management Initiative (COAMI)

A New Vision for Chronic Osteoarthritis Management A Call to Action from the Chronic Osteoarthritis Management Initiative (COAMI) Prepared by the United.

Comparisons of patients’, clinicians’ and researchers’ agendas Sandy Oliver, Reader in Public Policy Sub-brand to go here.

The James Lind Alliance ….. the story so far. NICE Conference Tackling Health Priorities 7 th December 2006.

Why we need to change. What is Healthier Together? A look at the way health services are delivered Looking at services provided in hospitals Looking at.

Taken from presentations given at the 2013 National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Conference, London 9–10 October.

Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator, James Lind Initiative ‘Putting people first in research’ INVOLVE.

Osteoarthritis Implementing NICE guidance 2008 NICE clinical guideline 59.

Routine data and opportunities to improve patient outcomes Iain Chalmers Coordinator, James Lind Initiative National Institute of Health Research National.

The James Lind Alliance Tackling treatment uncertainties together Lester Firkins, John Scadding and Mark Fenton INVOLVE Conference 2006.

Cochrane Agenda and Priority Setting Methods Group (CAPSMG)

SEBs: “What do patients say? Presented by Cheryl L. Koehn 2015 CADTH Symposium Saskatoon, Saskatchewan April 14, 2015.

CMS 5 STARS PROGRAM MedPOINT Management.

The Scope of Musculoskeletal Disease Treatment and Costs Prof Stephen Graves University of Melbourne.

Multi discipilinary team approach in Breast cancer (1) Fatih Agalar, MD, FACS, FEBS (hon) Prof of Surgery.

Research Priorities for Osteoarthritis of the Knee Chard JA, Tallon D, Dieppe PA.

Adams, J 1 ; Hislop, K. 1, Hammond, A. 2, Dziedzic, K. 3, Gooberman-Hill, R. 4, Stokes, M. 1, Burridge J 1., Arden, N. 5, Lewis, M. 3, Hutt Greenyer, C.,

The Physical Therapy Profession and APTA. Who We Are.

Developing a National Paediatric Diabetes Plan: What are the key issues for education? Dr. Sheridan Waldron HCP Education Lead for Children and Young people.

Curriculum Development For Adult Learners. Basics Educational objective- – What they will learn – Learning needs assessment or gap analysis Learner outcomes-

MUSCULOSKELETAL DISEASES National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.

SPU Medical Faculty English 3 What Is Orthopedics? M.A.Kubtan MD - FRCS.

By: Brandon Jamison, Tucker Dodson, Nami Small.  There are several conditions can cause elbow pain and disability, and lead patients and their doctors.

The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.

Paper 1: How to increase value and reduce waste when research priorities are set Iain Chalmers Coordinator, James Lind Initiative Launch of Lancet Series.

An introduction to the JLA. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference does it make?

Who are they? Archie Cochrane The Cochrane Collaboration Formed in ,000+ people in 80+ countries 50 Collaborative Review Groups 12 Centres, Fields,

An introduction to the JLA Katherine Cowan. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference.

SEC Engaging Leeds Welcome to the Public Engagement Symposium at SEC Chaired by Alexa Ruppertsberg, FMH.

James Lind Alliance Working Partnership on Urinary Incontinence.

THE COCHRANE LIBRARY ON WILEY INTERSCIENCE. Presentation Agenda Brief introduction of Evidence-Based Medicine theories The Cochrane Collaboration – origins,

Reducing waste in deciding what research to do Iain Chalmers Coordinator, James Lind Initiative NIHR Trainees Meeting Leeds, 26 November 2013.

Experimental studies Jean-François Boivin 25 October 2010.

Supporting Informed Formulary Decision Making: CADTH’s Common Drug Review Denis Bélanger, Director, CADTH New Brunswick Stroke Summit November 27, 2010,

February February 2008 Evidence Based Medicine –Evidence Based Medicine Centre –Best Practice –BMJ Clinical Evidence –BMJ Best.

MEDICARE Presented By WIA Warner Insurance Agency.

Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.

Evidence Based Medicine. What is Evidence Based Medicine? What qualifies as Evidence Based Medicine? Does Airrosti treat patients by utilizing an Evidence.

Knowledge Translation I. A Brief History. Formal Definition of KT Knowledge translation was first defined as “the exchange, synthesis and ethically sound.

IRIS Identification and Referral to Improve Safety “If they ask I would answer” Judy Barber Islington IRIS Advocate Educator © Bristol University 2007.

Open to all: the role of public involvement in health research Faculty of Health and Social Care, Open University, Wednesday 9 th December 2015 Simon Denegri,

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.

Knowledge management and information and communication technology International Clinical Epidemiology Network, XIXth annual meeting Kunming, China Fiona.

Review of 10 years Evidence for up-to-date clinical dental practice – a review of 10 years of the Cochrane Oral Health Group 30 th -31 st May 2006, Manchester.

Why are systematic reviews important? Iain Chalmers Editor, James Lind Library Cochrane Workshop Independent University, Bangladesh.

Osteoarthritis By: Megan Rogers. What is it? “wear-and-tear” arthritis affects joints in: hips knees lower back hands neck.

Acupuncture in Pain Management Zekeriya AKTÜRK Şifa University Medical Faculty, Department of Family Medicine 17 March 2016

PROMs and PREMs Thursday 14 th November 2013 Chris Graham

Cochrane Agenda and Priority Setting Methods Group (CAPSMG)

Managing Osteoarthritis of the Knee

Right Care Programme in West Essex

Evidenced-Based Medicine

Treatment for Acute Anterior Cruciate Ligament (ACL) Tear

Musculoskeletal Health in Europe

Clinical Reader in Clinical Pharmacology

Health-care interactions and placebo effects:

ملتقى أبوظبي الإقتصادي الثالث

Making Decisions With Your Osteoarthritis Patients

St Peters Hospice Services

Ten Key Trials in Cardiovascular Surgery

The MSK-HQ Developing a generic Musculoskeletal Patient Reported Outcome Measure Policy & Public Affairs Team, Arthritis Research UK e.

You can access NHS physiotherapy without going to your GP first with go2physio.

Clinical Decision Support In Action: Back Pain/Surgery

D.J. Hunter Osteoarthritis and Cartilage

The Research Question Lateral epicondylosis (tennis elbow) is common, debilitating and often refractory to routine care. Prolotherapy, an injection-based.

Presentation transcript:

James Lind Initiative Database of Uncertainties about the Effects of Treatments (DUETs) what gaps in the evidence matter to patients and doctors? Iain Chalmers NLH Eyes and Vision Specialist Library Birmingham, 14 March 2007

James Lind Initiative Consequences of maldistribution of resources for research

James Lind Initiative

Within treatment evaluation there are two important problems

James Lind Initiative First problem Researchers ignore patients’ & clinicians’ questions

James Lind Initiative Osteoarthritis of the knee Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000;355:

James Lind Initiative

1 st choices among research priorities in survey of 67 patients Knee replacement (35.8) Education and advice (20.9) Complementary therapy (6.0) Tablets (4.5) Injections in the knee (4.5) Physical therapy (3.0) No treatment at all (1.5) Miscellaneous other priorities (23.9)

James Lind Initiative Analysis of 460 randomised trials of treatments for osteoarthritis of the knee 380 trials of drugs 29 trials of complementary therapies 24 trials of physiotherapy/exercise 14 trials of education 13 trials of surgery

James Lind Initiative Second problem Researchers ignore treatment outcomes that are important to patients

James Lind Initiative Priority treatment outcome from a survey of patients with rheumatoid arthritis was not pain

James Lind Initiative Priority treatment outcome from a survey of patients with rheumatoid arthritis was not pain It was fatigue!

James Lind Initiative An initiative of the National Therapeutic Ignorance Service

James Lind Initiative DUETs’ working definition of uncertainty about the effects of treatments No up-to-date systematic reviews exist OR Up-to-date systematic reviews show that uncertainty exists

James Lind Initiative

The Specialist Libraries of the National Library for Health [NLH] are now assuming responsibility for developing and maintaining DUETs modules within their respective spheres of responsibility.

James Lind Initiative

The DUETs Core Team would be delighted if members of the NLH Eyes & Vision Specialist Library team and their colleagues would like to develop and manage a DUETs module within their sphere of responsibility.

James Lind Initiative

To visit DUETs go to: